TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

A. DeLuca, M. Frick, E. Lessem, J. Kanouse, D. Wegener and L. Ruiz Mingote

Activism on rifapentine pricing: removing cost barriers to improve the uptake of tuberculosis research innovations

By A. DeLuca, M. Frick, E. Lessem, J. Kanouse, D. Wegener and L. Ruiz Mingote
Published: Jan. 11, 2015, 9:50 p.m.· Tags: Access, Advocacy

The article details the advocacy campaign that led Sanofi to decrease the price of TB drug rifapentine by 57% in the United States.

Read More →

Page 1 of 1 · Total posts: 1

1